Pharmaceutical Benefit Design: Helping Employers Understand, Assess, Select and Manage Pharmacy Benefits
This guide, produced by the National Business Group on Health’s Pharmaceutical Council, is designed to educate employers on pharmaceutical benefit design – to deepen understanding and simplify decision making, helping benefits professionals keep up with a rapidly evolving pharmaceutical industry, and maintain fair and affordable benefits.
E.V.I.dently May 2013
Message From NPCThe Role of Pharmaceuticals in Health Insurance ExchangesOne of the most pressing issues in the implementation of the Affordable Care...
The Role of Pharmaceuticals in Health Insurance Exchanges
As part of the implementation of the Affordable Care Act, a series of state health insurance exchanges are being established across the United States...A Look at Rx Coverage and Cost in the New Health Insurance Exchanges
National Pharmaceutical Chief Science Officer Dr. Robert Dubois will lead a panel discussion, "Capturing the Value of Pharmaceuticals--A Look at Rx...
NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer
WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...
NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer
WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity
(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...New Survey Shows Employers Eyeing CER, PCORI for Health Information
Washington, DC, June 22, 2011--Employers are aware of comparative effectiveness research (CER) and its potential to answer critical questions about...Study Sheds New Light on the Impact of Medication Adherence, Multiple Chronic Diseases and Health Risks in the Workplace
(Chicago -- June 16, 2011) A new study suggests that while medication adherence is a critical element in reducing the impact of illness, employers...
Comparative Effectiveness Research and the Changing Health Care Landscape
This content appeared in the January 2, 2012 print edition of Chain Drug Review. In the span of just one year, the health care landscape has...Medicare Part D, Adherence, and the Value of Pharmaceuticals
Before enactment of the health care reform legislation two years ago, the most significant change in the health care landscape over the past decade...Linking Chronic Conditions to Medication Adherence and Productivity
It's no secret that chronic disease is the major driver of health care costs in the United States, accounting for two-thirds of the rise in health...Comparative Effectiveness Research: What Will Employers Do With the Information?
For years now, employers have expressed concern about the cost of providing health care to their employees and its impact on the competitiveness of...
Do Patients Understand Comparative Effectiveness Research?
Marc Boutin, EVP...PCORI Outlines Efforts to Engage Patients
Dr. Rachael Fleurence, Scientist,Patient-Centered Outcomes Research Institute, outlines the many ways heragency is engaging patients and other...Patient Usability Criteria for Comparative Effectiveness Research
Marc Boutin, EVP...Getting Patients Engaged in Comparative Effectiveness Research
Marc Boutin, EVP...The Role of Pharmaceuticals in Health Insurance Exchanges
As part of the implementation of the Affordable Care Act, a series of state health insurance exchanges are being established across the United States...A Look at Rx Coverage and Cost in the New Health Insurance Exchanges
National Pharmaceutical Chief Science Officer Dr. Robert Dubois will lead a panel discussion, "Capturing the Value of Pharmaceuticals--A Look at Rx...NPC's Dr. Dubois Talks ACO Expectations at AMCP Meeting
NPC's Chief Science Officer Dr. Robert Dubois chats with the American Journal of Managed Care about expectations for implementing accountable care...NPC to Present at IBI/NBCH 2013 Health and Productivity Forum
NPC Director of Policy Research Dr. Daryl Pritchard will speak on employer challenges in addressing specialty pharmacy-related impacts at the...Research
Intended and Unintended Consequences of HMO Cost Containment Strategies: Results from the Managed Care Outcomes Project
In examining the various cost-containment strategies
- 1 of 15
- >
Commentary & Testimony
Comparative Effectiveness Research and the Changing Health Care Landscape
Medicare Part D, Adherence, and the Value of Pharmaceuticals
Linking Chronic Conditions to Medication Adherence and Productivity
Comparative Effectiveness Research: What Will Employers Do With the Information?
Moving from “Comparative” to “Effectiveness” in Health Care Treatments